Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses

Genetics and Molecular Biology

Volumn 35, Issue 1, 2012, Pages 53-56

  Herman, Sandra ^a   Varga, Dominic ^a   Deissler, Heidrun L ^a   Kreienberg, Rolf ^a   Deissler, Helmut ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

DNA sequencing; Hereditary breast cancer; Model calculations; Mutation analysis; PCR

Indexed keywords

ADULT; AMPLICON; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EXON; FAMILY HISTORY; FAMILY STUDY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE LOSS; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; HUMAN; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; OVARY CANCER; POLYMERASE CHAIN REACTION; PROBABILITY;

EID: 84858192792     PISSN: 14154757     EISSN: 16784685     Source Type: Journal    
DOI: 10.1590/S1415-47572012005000001     Document Type: Article

References (6)

1. Arnold N, Peper H, Bandick K, Kreikemeier M, Karow D, Teegen B and Jonat W (2002) Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 782:99-104.
2. Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendok R, Menko FA, et al. (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449-1453.
3. King MC, Marks JH and Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646.
4. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
5. van der Stoep N, van Paridon CD, Janssens T, Krenkova P, Stambergova A, Macek M, Matthijs G and Bakker E (2009) Diagnostic guidelines for high-resolution melting curve (HRM) analysis: an interlaboratory validation of BRCA1 mutation scanning using the 96-well LightScanner. Hum Mutat 30:899-909.
6. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C and Micklem G, et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792.